Terms: = Prostate cancer AND ER, estrogen receptor AND Clinical Outcome
20 results:
1. Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis.
Rajan A; Nadhan R; Latha NR; Krishnan N; Warrier AV; Srinivas P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188482. PubMed ID: 33260050
[TBL] [Abstract] [Full Text] [Related]
2. Serotonin receptor 4 (5-hydroxytryptamine receptor Type 4) regulates expression of estrogen receptor beta and cell migration in hormone-naive prostate cancer.
Nakamura Y; Ise K; Yamazaki Y; Fujishima F; McNamara KM; Sasano H
Indian J Pathol Microbiol; 2017; 60(1):33-37. PubMed ID: 28195088
[TBL] [Abstract] [Full Text] [Related]
3. WDR5 Expression Is Prognostic of Breast cancer outcome.
Dai X; Guo W; Zhan C; Liu X; Bai Z; Yang Y
PLoS One; 2015; 10(9):e0124964. PubMed ID: 26355959
[TBL] [Abstract] [Full Text] [Related]
4. PTEN Loss Is Associated with Worse outcome in HER2-Amplified Breast cancer Patients but Is Not Associated with Trastuzumab Resistance.
Stern HM; Gardner H; Burzykowski T; Elatre W; O'Brien C; Lackner MR; Pestano GA; Santiago A; Villalobos I; Eiermann W; Pienkowski T; Martin M; Robert N; Crown J; Nuciforo P; Bee V; Mackey J; Slamon DJ; Press MF
Clin Cancer Res; 2015 May; 21(9):2065-74. PubMed ID: 25649019
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
[TBL] [Abstract] [Full Text] [Related]
6. High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer.
Abd Elmageed ZY; Moroz K; Srivastav SK; Fang Z; Crawford BE; Moparty K; Thomas R; Abdel-Mageed AB
Carcinogenesis; 2013 Sep; 34(9):2017-23. PubMed ID: 23658372
[TBL] [Abstract] [Full Text] [Related]
7. estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease.
Zellweger T; Stürm S; Rey S; Zlobec I; Gsponer JR; Rentsch CA; Terracciano LM; Bachmann A; Bubendorf L; Ruiz C
Endocr Relat Cancer; 2013 Jun; 20(3):403-13. PubMed ID: 23580588
[TBL] [Abstract] [Full Text] [Related]
8. Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.
Hosseini-Beheshti E; Pham S; Adomat H; Li N; Tomlinson Guns ES
Mol Cell Proteomics; 2012 Oct; 11(10):863-85. PubMed ID: 22723089
[TBL] [Abstract] [Full Text] [Related]
9. Post-translational modifications of nuclear receptors and human disease.
Anbalagan M; Huderson B; Murphy L; Rowan BG
Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
[TBL] [Abstract] [Full Text] [Related]
10. Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex.
Re A; Aiello A; Nanni S; Grasselli A; Benvenuti V; Pantisano V; Strigari L; Colussi C; Ciccone S; Mazzetti AP; Pierconti F; Pinto F; Bassi P; Gallucci M; Sentinelli S; Trimarchi F; Bacchetti S; Pontecorvi A; Lo Bello M; Farsetti A
Mol Endocrinol; 2011 Dec; 25(12):2003-16. PubMed ID: 22052999
[TBL] [Abstract] [Full Text] [Related]
11. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner.
Mahadevan NR; Rodvold J; Almanza G; Pérez AF; Wheeler MC; Zanetti M
BMC Cancer; 2011 Jun; 11():229. PubMed ID: 21649922
[TBL] [Abstract] [Full Text] [Related]
12. Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers.
Das K; Lorena PD; Ng LK; Shen L; Lim D; Siow WY; Narasimhan K; Teh M; Choolani M; Putti TC; Salto-Tellez M
Pathology; 2010; 42(6):540-6. PubMed ID: 20854072
[TBL] [Abstract] [Full Text] [Related]
13. Identification of 5 novel genes methylated in breast and other epithelial cancers.
Hill VK; Hesson LB; Dansranjavin T; Dallol A; Bieche I; Vacher S; Tommasi S; Dobbins T; Gentle D; Euhus D; Lewis C; Dammann R; Ward RL; Minna J; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Mar; 9():51. PubMed ID: 20205715
[TBL] [Abstract] [Full Text] [Related]
14. Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.
Nanni S; Benvenuti V; Grasselli A; Priolo C; Aiello A; Mattiussi S; Colussi C; Lirangi V; Illi B; D'Eletto M; Cianciulli AM; Gallucci M; De Carli P; Sentinelli S; Mottolese M; Carlini P; Strigari L; Finn S; Mueller E; Arcangeli G; Gaetano C; Capogrossi MC; Donnorso RP; Bacchetti S; Sacchi A; Pontecorvi A; Loda M; Farsetti A
J Clin Invest; 2009 May; 119(5):1093-108. PubMed ID: 19363294
[TBL] [Abstract] [Full Text] [Related]
15. Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
Liu S; Chia SK; Mehl E; Leung S; Rajput A; Cheang MC; Nielsen TO
Breast Cancer Res Treat; 2010 Jan; 119(1):53-61. PubMed ID: 19205877
[TBL] [Abstract] [Full Text] [Related]
16. PACK: Profile Analysis using Clustering and Kurtosis to find molecular classifiers in cancer.
Teschendorff AE; Naderi A; Barbosa-Morais NL; Caldas C
Bioinformatics; 2006 Sep; 22(18):2269-75. PubMed ID: 16682424
[TBL] [Abstract] [Full Text] [Related]
17. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
McCarty MF
Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
[TBL] [Abstract] [Full Text] [Related]
18. prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score.
Torlakovic E; Lilleby W; Torlakovic G; Fosså SD; Chibbar R
Hum Pathol; 2002 Jun; 33(6):646-51. PubMed ID: 12152165
[TBL] [Abstract] [Full Text] [Related]
19. Frequent loss of estrogen receptor-beta expression in prostate cancer.
Horvath LG; Henshall SM; Lee CS; Head DR; Quinn DI; Makela S; Delprado W; Golovsky D; Brenner PC; O'Neill G; Kooner R; Stricker PD; Grygiel JJ; Gustafsson JA; Sutherland RL
Cancer Res; 2001 Jul; 61(14):5331-5. PubMed ID: 11454669
[TBL] [Abstract] [Full Text] [Related]
20. Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome.
Zunarelli E; Nicoll JA; Migaldi M; Trentini GP
Breast Cancer Res Treat; 2000 Oct; 63(3):193-8. PubMed ID: 11110053
[TBL] [Abstract] [Full Text] [Related]
